Core Points - The 2025 High-Quality Development Forum for Listed Companies and the 27th Golden Bull Award Ceremony took place in Nantong, Jiangsu, with the theme "Moving Forward with New Initiatives for a Sustainable Future" [1] - Guoen Co., Ltd. received the "2024 Golden Bull Secretary Award," highlighting its achievements in corporate governance and investor relations [1][5] Group 1: Company Overview - Guoen Co., Ltd. operates a vertically integrated industrial platform focused on the large chemical and health industries, implementing a "one body, two wings" development strategy [4] - The company has optimized its industrial structure, developing a comprehensive industrial cluster in new chemical materials, including green petrochemicals, organic polymer modifications, and lightweight components for new energy vehicles [4] - Guoen also holds a controlling stake in Dongbao Biological, which specializes in gelatin and collagen products, forming a diversified enterprise group in the health sector [4] Group 2: Award Significance - The Golden Bull Award is a prestigious evaluation activity organized by China Securities Journal, emphasizing transparency, professionalism, and credibility in the capital market [4] - The award aims to create a platform for authoritative recognition and brand display for listed companies, promoting healthy development within the capital market [4][5] - The awards include categories such as "Most Investment Value Award," "Golden Bull Outstanding Entrepreneur Award," and "Golden Bull Secretary Award," recognizing excellence in corporate governance and investor relations [5]

Core Viewpoint - The 2025 High-Quality Development Forum for Listed Companies and the 27th Golden Bull Award Ceremony took place in Nantong, Jiangsu, highlighting the importance of transparency and investor relations in the capital market [1][4]. Group 1: Company Overview - Saito Bio focuses on the research and production of steroid drug intermediates, leveraging gene engineering and microbial transformation technologies [4]. - The company has achieved large-scale application of biopharmaceutical technology in the steroid drug sector through years of independent research and technology introduction [4]. Group 2: Awards and Recognition - The Golden Bull Award is a prestigious evaluation event organized by China Securities Journal, emphasizing transparency and professionalism in the capital market [4][5]. - The awards include categories such as "Most Investment Value Award," "Golden Bull Outstanding Entrepreneur Award," and "Golden Bull Secretary Award," with the latter recognizing outstanding performance in corporate governance and investor relations [5]. Group 3: Investor Relations - Saito Bio has prioritized information disclosure and investor relations management since its listing, actively engaging with investors through various channels and timely responses [4]. - The company has received positive feedback from investors for its commitment to transparency and effective communication [4].